Gauss

Recombinant Mouse IFN-béta (ELISA Std.) 4 pack

Réf. UGAP : 3689608 Réf. Fournisseur : 581309 Réf. Constructeur : 581309
Recombinant Mouse IFN-béta (ELISA Std.) 4 pack
Recombinant Mouse IFN-béta (ELISA Std.) 4 pack
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

Interferon-β is a member of the type I interferon class. Type I IFNs are involved in the innate immune system, being released non-specifically during the early stage of infection in response to stimuli such as viruses, dsRNA, LPS, and bacterial components. Once secreted by virus-infected or activated cells, they bind to the IFNα/β receptor (IFNAR), which is found on almost all cell types, and, via the JAK-STAT pathway, induce the expression of hundreds of IFN-stimulated genes (ISGs). While the function of many of these proteins remains to be elucidated, a hallmark of type I IFNs is their anti-viral activities, both general and specific against particular viruses. Type I IFNs also regulate cell growth and apoptosis, and exert various immunomodulatory and inflammatory effects. As such, they are also clinically relevant, both as therapeutics and as targets of inhibition for the treatment of various autoimmune diseases and cancer. Mouse IFN-β is a about 20 kD monomeric glycoprotein. It has 50% amino acid sequence homology with mouse IFN-α, its closest related protein, and 62% homology with human IFN-β. IFN-β is currently the therapeutic of choice for treating multiple sclerosis.;

En savoir plus

Garantie

Garantie 0 Mois

Description

Interferon-β is a member of the type I interferon class. Type I IFNs are involved in the innate immune system, being released non-specifically during the early stage of infection in response to stimuli such as viruses, dsRNA, LPS, and bacterial components. Once secreted by virus-infected or activated cells, they bind to the IFNα/β receptor (IFNAR), which is found on almost all cell types, and, via the JAK-STAT pathway, induce the expression of hundreds of IFN-stimulated genes (ISGs). While the function of many of these proteins remains to be elucidated, a hallmark of type I IFNs is their anti-viral activities, both general and specific against particular viruses. Type I IFNs also regulate cell growth and apoptosis, and exert various immunomodulatory and inflammatory effects. As such, they are also clinically relevant, both as therapeutics and as targets of inhibition for the treatment of various autoimmune diseases and cancer. Mouse IFN-β is a about 20 kD monomeric glycoprotein. It has 50% amino acid sequence homology with mouse IFN-α, its closest related protein, and 62% homology with human IFN-β. IFN-β is currently the therapeutic of choice for treating multiple sclerosis.;

Caractéristiques

Fournisseur
BioLegend Europe BV
Marque
BIOLEGEND
Référence fabricant
581309
Référence distributeur
581309
Vendu par
4 pack
Quantité
N/A
Lieu de fabrication
USA
Lieu de stockage
Pays-Bas ou USA
Soumis à carboglace
non
Classement dans le catalogue fournisseur
Recombinant Protein
Certification
RUO
Type d’application
ELISA
Type de produit
protéine
Température de conservation (°C)
entre 2 et 8 °C
Température de transport
ambiante
Méthode de détection
colorimétrique
Méthode de dosage
ELISA
Organisme cible
Mouse
Source biologique
293E cells
Seuil de coupure des masses moléculaires MWCO
The 175 amino acid recombinant protein has a predicted molecular mass of approximately 21.2 kD. The DTT-reduced and non-reduced protein migrates at approximately 36 kD by SDS-PAGE. Da
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our online tools.)
Pureté
>98%, as determined by Coomassie stained SDS-PAGE prior to lyophilization. %
Matière dangereuse
Non
Code douanier
38220000
Classement NCBI
15977
Nomenclature Nacres
NA.84
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA84
Nomenclature CNRS
NA84
Nomenclature CHU
18.551
Nomenclature DGOS
LD11AOOO
Reprise en cas d’erreur client
non